Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

A Comparison of ROCK Inhibitors on Human Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Neuron-Like Cells

  • Lee, Hyun-Sun (Cancer Research Institute and Department of Biomedical Sciences, The Catholic University of Korea, College of Medicine) ;
  • Kim, Kwang-Sei (Cancer Research Institute and Department of Biomedical Sciences, The Catholic University of Korea, College of Medicine) ;
  • O, Eun-Ju (Cancer Research Institute and Department of Biomedical Sciences, The Catholic University of Korea, College of Medicine) ;
  • Joe, Young-Ae (Cancer Research Institute and Department of Biomedical Sciences, The Catholic University of Korea, College of Medicine)
  • Received : 2010.05.25
  • Accepted : 2010.05.29
  • Published : 2010.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Bone marrow-derived mesenchymal stem cells (BM-MSC) are a multipotent cell population that can differentiate into neuron-like cells. Previously it has been reported that murine BM-MSC can differentiate into neuron-like cells by co-treatment with a Rho-associated kinase (ROCK) inhibitor -Y27632 and $CoCl_2$. In this study, we compared several ROCK inhibitors for the ability to induce human BM-MSCs to differentiate into neuron-like cells in the presence of $CoCl_2$. Y27632 with high specificity for ROCK at 1-30 ${\mu}M$ was best at inducing neuronal differentiation of MSCs. Compared to HA1077 and H1152, which also effectively induced morphological change into neuron-like cells, Y27632 showed less toxicity even at 100 ${\mu}M$, and resulted in longer multiple branching processes at a wide range of concentrations at 6 h and 72 h post-induction. H89, however, which has less specificity by inhibition of protein kinase A, S6 kinase 1 and MSK1 with similar or greater potency, was less effective at inducing neuronal differentiation of MSCs. Simvastatin, which can inhibit Rho, Ras, and Rac by blocking the synthesis of isoprenoid intermediates, showed little activity for inducing morphological changes of MSCs into neuron-like cells. Accordingly, the expression patterns for neuronal cell markers,including ${\beta}$-tubulin III, neuron-specific enolase, neurofilament, and microtubule-associated protein, were consistent with the pattern of the morphological changes. The data suggest that the ROCK inhibitors with higher specificity are more effective at inducing neuronal differentiation of MSCs.

Keywords

References

  1. Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M. and Chopp,M. (2001). Therapeutic benefit of intravenous administrationof bone marrow stromal cells after cerebral ischemia in rats.Stroke 32, 1005-1011. https://doi.org/10.1161/01.STR.32.4.1005
  2. Davies, S. P., Reddy, H., Caivano, M. and Cohen, P. (2000).Specificity and mechanism of action of some commonlyused protein kinase inhibitors. Biochem. J. 351, 95-105. https://doi.org/10.1042/0264-6021:3510095
  3. Dezawa, M., Ishikawa, H., Hoshino, M., Itokazu, Y. and Nabeshima,Y. (2005). Potential of bone marrow stromal cells inapplications for neuro-degenerative, neuro-traumatic andmuscle degenerative diseases. Curr. Neuropharmacol. 3,257-266. https://doi.org/10.2174/157015905774322507
  4. Grove, J. E., Bruscia, E. and Krause, D. S. (2004). Plasticity ofbone marrow-derived stem cells. Stem Cells 22, 487-500. https://doi.org/10.1634/stemcells.22-4-487
  5. Heng, B. C. (2009). Effect of Rho-associated kinase (ROCK)inhibitor Y-27632 on the post-thaw viability of cryopreservedhuman bone marrow-derived mesenchymal stem cells.Tissue Cell 41, 376-380. https://doi.org/10.1016/j.tice.2009.01.004
  6. Hofstetter, C. P., Schwarz, E. J., Hess, D., Widenfalk, J., El Manira,A., Prockop, D. J. and Olson, L. (2002). Marrow stromal cellsform guiding strands in the injured spinal cord and promoterecovery. Proc. Natl. Acad. Sci. U S A 99, 2199-2204. https://doi.org/10.1073/pnas.042678299
  7. Kubo, T., Yamaguchi, A., Iwata, N. and Yamashita, T. (2008).The therapeutic effects of Rho-ROCK inhibitors on CNSdisorders. Ther. Clin. Risk Manag. 4, 605-615. https://doi.org/10.2147/TCRM.S2907
  8. Li, Y., Chen, J. and Chopp, M. (2001). Adult bone marrow transplantationafter stroke in adult rats. Cell Transplant. 10,31-40.
  9. Liao, J. K., Seto, M. and Noma, K. (2007). Rho kinase (ROCK)inhibitors. J. Cardiovasc. Pharmacol. 50, 17-24. https://doi.org/10.1097/FJC.0b013e318070d1bd
  10. Luo, L. (2000). Rho GTPases in neuronal morphogenesis. Nat.Rev. Neurosci. 1, 173-180. https://doi.org/10.1038/35044547
  11. Mahmood, A., Lu, D., Wang, L., Li, Y., Lu, M. and Chopp, M.(2001). Treatment of traumatic brain injury in female rats withintravenous administration of bone marrow stromal cells.Neurosurgery 49, 1196-1203; discussion 1203-1194. https://doi.org/10.1097/00006123-200111000-00031
  12. Olson, M. F. (2008). Applications for ROCK kinase inhibition.Curr. Opin. Cell Biol. 20, 242-248. https://doi.org/10.1016/j.ceb.2008.01.002
  13. Pacary, E., Legros, H., Valable, S., Duchatelle, P., Lecocq, M.,Petit, E., Nicole, O. and Bernaudin, M. (2006). Synergisticeffects of CoCl(2) and ROCK inhibition on mesenchymalstem cell differentiation into neuron-like cells. J. Cell Sci.119, 2667-2678. https://doi.org/10.1242/jcs.03004
  14. Pacary, E., Petit, E. and Bernaudin, M. (2008). Concomitantinhibition of prolyl hydroxylases and ROCK initiates differentiationof mesenchymal stem cells and PC12 towards theneuronal lineage. Biochem. Biophys. Res. Commun. 377,400-406. https://doi.org/10.1016/j.bbrc.2008.09.145
  15. Pacary, E., Tixier, E., Coulet, F., Roussel, S., Petit, E. and Bernaudin,M. (2007). Crosstalk between HIF-1 and ROCKpathways in neuronal differentiation of mesenchymal stemcells, neurospheres and in PC12 neurite outgrowth. Mol. CellNeurosci. 35, 409-423. https://doi.org/10.1016/j.mcn.2007.04.002
  16. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K.,Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W.,Craig, S. and Marshak, D. R. (1999). Multilineage potential ofadult human mesenchymal stem cells. Science 284, 143-147. https://doi.org/10.1126/science.284.5411.143
  17. Sanchez-Ramos, J., Song, S., Cardozo-Pelaez, F., Hazzi, C.,Stedeford, T., Willing, A., Freeman, T. B., Saporta, S.,Janssen, W., Patel, N., Cooper, D. R. and Sanberg, P. R.(2000). Adult bone marrow stromal cells differentiate intoneural cells in vitro. Exp. Neurol. 164, 247-256. https://doi.org/10.1006/exnr.2000.7389
  18. Sasaki, Y., Suzuki, M. and Hidaka, H. (2002). The novel andspecific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing moleculefor Rho-kinase-involved pathway. Pharmacol. Ther. 93,225-232. https://doi.org/10.1016/S0163-7258(02)00191-2
  19. Schmandke, A. and Strittmatter, S. M. (2007). ROCK and Rho:biochemistry and neuronal functions of Rho-associatedprotein kinases. Neuroscientist 13, 454-469. https://doi.org/10.1177/1073858407303611
  20. Shi, J. and Wei, L. (2007). Rho kinase in the regulation of cell deathand survival. Arch. Immunol. Ther. Exp. (Warsz) 55, 61-75. https://doi.org/10.1007/s00005-007-0009-7
  21. Van Aelst, L. and Cline, H. T. (2004). Rho GTPases and activitydependentdendrite development. Curr. Opin. Neurobiol. 14,297-304. https://doi.org/10.1016/j.conb.2004.05.012
  22. Woodbury, D., Schwarz, E. J., Prockop, D. J. and Black, I. B.(2000). Adult rat and human bone marrow stromal cellsdifferentiate into neurons. J. Neurosci. Res. 61, 364-370. https://doi.org/10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C

Cited by

  1. A ROCK Inhibitor Blocks the Inhibitory Effect of Chondroitin Sulfate Proteoglycan on Morphological Changes of Mesenchymal Stromal/Stem Cells into Neuron-Like Cells vol.21, pp.6, 2013, https://doi.org/10.4062/biomolther.2013.041
  2. Promotion of mouse embryonic stem cell differentiation by Rho kinase inhibitor Y-27632 vol.579, 2014, https://doi.org/10.1016/j.neulet.2014.07.011
  3. Rho kinase inhibitor Y-27632 promotes neuronal differentiation in mouse embryonic stem cells via phosphatidylinositol 3-kinase vol.615, 2016, https://doi.org/10.1016/j.neulet.2016.01.022
  4. A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization vol.118, pp.5, 2017, https://doi.org/10.1002/jcb.25732
  5. Enhancement of Endothelial Progenitor Cell Numbers and Migration by H1152, a Rho Kinase Specific Inhibitor vol.76, pp.1, 2010, https://doi.org/10.1271/bbb.110468